Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Influence of azithromycin and allograft rejection on the post-lung transplant microbiota.

Spence CD, Vanaudenaerde B, Einarsson GG, Mcdonough J, Lee AJ, Johnston E, Verleden GM, Elborn JS, Dupont LJ, Van Herck A, Gilpin DF, Vos R, Tunney MM, Verleden SE.

J Heart Lung Transplant. 2019 Nov 21. pii: S1053-2498(19)31759-0. doi: 10.1016/j.healun.2019.11.007. [Epub ahead of print]

PMID:
31812487
2.

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial.

Vermeersch K, Belmans A, Bogaerts K, Gyselinck I, Cardinaels N, Gabrovska M, Aumann J, Demedts IK, Corhay JL, Marchand E, Slabbynck H, Haenebalcke C, Vermeersch S, Verleden GM, Troosters T, Ninane V, Brusselle GG, Janssens W; BACE trial investigators.

Respir Res. 2019 Oct 29;20(1):237. doi: 10.1186/s12931-019-1208-6.

3.

Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation: a single-center experience and review of literature.

Lebeer M, Kaes J, Lambrech M, Vanstapel A, Beeckmans H, Ambrocio GPL, Vanaudenaerde BM, Verleden SE, Verbeken EK, Neyrinck AP, Ceulemans LJ, Van Raemdonck DE, Verleden GM, Vos R; Leuven Lung Transplant Group.

Transpl Int. 2019 Oct 23. doi: 10.1111/tri.13544. [Epub ahead of print]

PMID:
31643104
4.

Mortality after lung transplantation: a single-centre cohort analysis.

Raskin J, Vanstapel A, Verbeken EK, Beeckmans H, Vanaudenaerde BM, Verleden SE, Neyrinck AP, Ceulemans LJ, Van Raemdonck DE, Verleden GM, Vos R; Leuven Lung Transplant Group.

Transpl Int. 2019 Oct 15. doi: 10.1111/tri.13540. [Epub ahead of print]

PMID:
31612514
5.

Airway morphometry in COPD with bronchiectasis: a view on all airway generations.

Everaerts S, McDonough JE, Verleden SE, Josipovic I, Boone M, Dubbeldam A, Mathyssen C, Serré J, Dupont LJ, Gayan-Ramirez G, Verschakelen J, Hogg JC, Verleden GM, Vanaudenaerde BM, Janssens W.

Eur Respir J. 2019 Nov 7;54(5). pii: 1802166. doi: 10.1183/13993003.02166-2018. Print 2019 Nov.

PMID:
31467117
6.

Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction.

Sacreas A, Taupin JL, Emonds MP, Daniëls L, Van Raemdonck DE, Vos R, Verleden GM, Vanaudenaerde BM, Roux A, Verleden SE; and the Leuven Lung Transplant Group.

Eur Respir J. 2019 Nov 7;54(5). pii: 1900847. doi: 10.1183/13993003.00847-2019. Print 2019 Nov.

PMID:
31439680
7.

Outcome of lung transplantation in non-idiopathic pulmonary fibrosis interstitial lung disease.

Bode H, Verleden SE, Wuyts WA, Yserbyt J, Verleden GM, Vos R.

Clin Transplant. 2019 Oct;33(10):e13661. doi: 10.1111/ctr.13661. Epub 2019 Aug 6.

PMID:
31286560
8.

Invited Commentary.

Van Raemdonck D, Vos R, Verleden GM, Neyrinck A.

Ann Thorac Surg. 2019 Nov;108(5):1526-1527. doi: 10.1016/j.athoracsur.2019.06.013. Epub 2019 Jul 2. No abstract available.

PMID:
31276646
9.

Chronic lung allograft dysfunction: light at the end of the tunnel?

Verleden SE, Vos R, Verleden GM.

Curr Opin Organ Transplant. 2019 Jun;24(3):318-323. doi: 10.1097/MOT.0000000000000632.

PMID:
31090642
10.

Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.

Vermeersch K, Gabrovska M, Aumann J, Demedts IK, Corhay JL, Marchand E, Slabbynck H, Haenebalcke C, Haerens M, Hanon S, Jordens P, Peché R, Fremault A, Lauwerier T, Delporte A, Vandenberk B, Willems R, Everaerts S, Belmans A, Bogaerts K, Verleden GM, Troosters T, Ninane V, Brusselle GG, Janssens W.

Am J Respir Crit Care Med. 2019 Oct 1;200(7):857-868. doi: 10.1164/rccm.201901-0094OC.

PMID:
31046405
11.

Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT.

Glanville AR, Verleden GM, Todd JL, Benden C, Calabrese F, Gottlieb J, Hachem RR, Levine D, Meloni F, Palmer SM, Roman A, Sato M, Singer LG, Tokman S, Verleden SE, von der Thüsen J, Vos R, Snell G.

J Heart Lung Transplant. 2019 May;38(5):483-492. doi: 10.1016/j.healun.2019.03.008. Epub 2019 Apr 3. No abstract available.

PMID:
31027539
12.

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT.

Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, Ensor CR, Gottlieb J, Hachem RR, Lama V, Martinu T, Neil DAH, Singer LG, Snell G, Vos R.

J Heart Lung Transplant. 2019 May;38(5):493-503. doi: 10.1016/j.healun.2019.03.009. Epub 2019 Apr 3. No abstract available.

PMID:
30962148
13.

Chronic lung allograft dysfunction: light at the end of the tunnel?

Verleden SE, Vos R, Verleden GM.

Curr Opin Organ Transplant. 2019 Apr 1. doi: 10.1097/MOT.0000000000000632. [Epub ahead of print]

PMID:
30939492
14.

Restoring Blood Supply to the Heart While Replacing the Lungs: Is It Worth the Risk?

Van Raemdonck D, Vos R, Van Cleemput J, Rega F, Rex S, Neyrinck A, Verleden GM.

Transplantation. 2019 Oct;103(10):1986-1987. doi: 10.1097/TP.0000000000002610. No abstract available.

PMID:
30801520
15.

Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival.

Yang JYC, Verleden SE, Zarinsefat A, Vanaudenaerde BM, Vos R, Verleden GM, Sarwal RD, Sigdel TK, Liberto JM, Damm I, Watson D, Sarwal MM.

J Clin Med. 2019 Feb 13;8(2). pii: E241. doi: 10.3390/jcm8020241.

16.

Double-lung versus heart-lung transplantation for precapillary pulmonary arterial hypertension: a 24-year single-center retrospective study.

Brouckaert J, Verleden SE, Verbelen T, Coosemans W, Decaluwé H, De Leyn P, Depypere L, Nafteux P, Van Veer H, Meyns B, Rega F, Van De Velde M, Poortmans G, Rex S, Neyrinck A, Van den Berghe G, Vlasselaers D, Van Cleemput J, Budts W, Vos R, Quarck R, Belge C, Delcroix M, Verleden GM, Van Raemdonck D.

Transpl Int. 2019 Jul;32(7):717-729. doi: 10.1111/tri.13409. Epub 2019 Mar 5.

PMID:
30735591
17.

Phenotypical diversity of airway morphology in chronic lung graft vs. host disease after stem cell transplantation.

Verleden SE, McDonough JE, Schoemans H, Knoop C, Verschakelen J, Dubbeldam A, Boone MN, Van Hoorebeke L, Verbeken E, Weynand B, Van Raemdonck D, Verleden GM, Vos R, Vanaudenaerde BM.

Mod Pathol. 2019 Jun;32(6):817-829. doi: 10.1038/s41379-019-0203-2. Epub 2019 Feb 5.

PMID:
30723292
18.

Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial.

Van Herck A, Frick AE, Schaevers V, Vranckx A, Verbeken EK, Vanaudenaerde BM, Sacreas A, Heigl T, Neyrinck AP, Van Raemdonck D, Dupont LJ, Yserbyt J, Verleden SE, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Mar;38(3):252-259. doi: 10.1016/j.healun.2018.12.006. Epub 2018 Dec 14.

PMID:
30686699
19.

Montelukast in chronic lung allograft dysfunction after lung transplantation.

Vos R, Eynde RV, Ruttens D, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck DE, Verleden GM; Leuven Lung Transplant Group.

J Heart Lung Transplant. 2019 May;38(5):516-527. doi: 10.1016/j.healun.2018.11.014. Epub 2018 Dec 6.

PMID:
30638839
20.

Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study.

Cebrià I Iranzo MÀ, Vos R, Verleden GM, Gosselink R, Langer D.

Arch Bronconeumol. 2019 May;55(5):239-245. doi: 10.1016/j.arbres.2018.11.003. Epub 2018 Dec 27. English, Spanish.

21.

Effects of Corticosteroid Treatment and Antigen Avoidance in a Large Hypersensitivity Pneumonitis Cohort: A Single-Centre Cohort Study.

De Sadeleer LJ, Hermans F, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, Verleden GM, Wuyts WA.

J Clin Med. 2018 Dec 21;8(1). pii: E14. doi: 10.3390/jcm8010014.

22.

Freedom from chronic lung allograft dysfunction (CLAD) or CLAD-free survival: What's in a name?

Verleden GM, Verleden SE, Vos R.

J Heart Lung Transplant. 2019 Jan;38(1):1-2. doi: 10.1016/j.healun.2018.11.005. Epub 2018 Nov 15. No abstract available.

PMID:
30497817
23.

Determinants of survival in lung transplantation patients with idiopathic pulmonary fibrosis: a retrospective cohort study.

Tuyls S, Verleden SE, Wuyts WA, Yserbyt J, Vos R, Verleden GM.

Transpl Int. 2019 Apr;32(4):399-409. doi: 10.1111/tri.13382. Epub 2018 Dec 21.

PMID:
30488486
24.

Validation of a post-transplant chronic lung allograft dysfunction classification system.

Van Herck A, Verleden SE, Sacreas A, Heigl T, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verbeken EK, Neyrinck AP, Van Raemdonck D, Verleden GM, Vos R.

J Heart Lung Transplant. 2019 Feb;38(2):166-173. doi: 10.1016/j.healun.2018.09.020. Epub 2018 Oct 4.

PMID:
30391199
25.

The common rejection module in chronic rejection post lung transplantation.

Sacreas A, Yang JYC, Vanaudenaerde BM, Sigdel TK, Liberto JM, Damm I, Verleden GM, Vos R, Verleden SE, Sarwal MM.

PLoS One. 2018 Oct 5;13(10):e0205107. doi: 10.1371/journal.pone.0205107. eCollection 2018.

26.

Role of 18F-FDG PET/CT in Restrictive Allograft Syndrome After Lung Transplantation.

Verleden SE, Gheysens O, Goffin KE, Vanaudenaerde BM, Verbeken EK, Weynand B, Van Raemdonck DE, Verleden GM, Vos R.

Transplantation. 2019 Apr;103(4):823-831. doi: 10.1097/TP.0000000000002393.

PMID:
30086092
27.

Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.

Vos R, Wuyts WA, Gheysens O, Goffin KE, Schaevers V, Verleden SE, Van Herck A, Sacreas A, Heigl T, McDonough JE, Yserbyt J, Godinas L, Dupont LJ, Neyrinck AP, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Verleden GM.

Am J Transplant. 2018 Dec;18(12):3045-3059. doi: 10.1111/ajt.15019. Epub 2018 Aug 17.

28.

A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis.

McDonough JE, Martens DS, Tanabe N, Ahangari F, Verleden SE, Maes K, Verleden GM, Kaminski N, Hogg JC, Nawrot TS, Wuyts WA, Vanaudenaerde BM.

Respir Res. 2018 Jul 9;19(1):132. doi: 10.1186/s12931-018-0838-4.

29.

Clinical behaviour of patients exposed to organic dust and diagnosed with idiopathic pulmonary fibrosis.

De Sadeleer LJ, Verleden SE, De Dycker E, Yserbyt J, Verschakelen JA, Verbeken EK, Nemery B, Verleden GM, Hermans F, Vanaudenaerde BM, Wuyts WA.

Respirology. 2018 Dec;23(12):1160-1165. doi: 10.1111/resp.13342. Epub 2018 Jun 13.

PMID:
29897160
30.

Living by numbers.

Van Raemdonck D, Neyrinck A, Vos R, Verleden GM.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):906-907. doi: 10.1016/j.jtcvs.2018.04.002. Epub 2018 Apr 12. No abstract available.

PMID:
29754792
31.

The aging lung: tissue telomere shortening in health and disease.

Everaerts S, Lammertyn EJ, Martens DS, De Sadeleer LJ, Maes K, van Batenburg AA, Goldschmeding R, van Moorsel CHM, Dupont LJ, Wuyts WA, Vos R, Gayan-Ramirez G, Kaminski N, Hogg JC, Janssens W, Verleden GM, Nawrot TS, Verleden SE, McDonough JE, Vanaudenaerde BM.

Respir Res. 2018 May 11;19(1):95. doi: 10.1186/s12931-018-0794-z.

32.

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.

Ruttens D, Verleden SE, Demeyer H, Van Raemdonck DE, Yserbyt J, Dupont LJ, Vanaudenaerde BM, Vos R, Verleden GM.

PLoS One. 2018 Apr 6;13(4):e0193564. doi: 10.1371/journal.pone.0193564. eCollection 2018.

33.

Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases: A Retrospective Observational Study of 938 Cases.

De Sadeleer LJ, Meert C, Yserbyt J, Slabbynck H, Verschakelen JA, Verbeken EK, Weynand B, De Langhe E, Lenaerts JL, Nemery B, Van Raemdonck D, Verleden GM, Wells AU, Wuyts WA.

Chest. 2018 Jun;153(6):1416-1423. doi: 10.1016/j.chest.2018.03.026. Epub 2018 Mar 30.

PMID:
29608882
34.

Multiple Solid Organ Transplantation in Telomeropathy: Case Series and Literature Review.

Lebeer M, Wuyts WA, Cassiman D, Laleman W, Nevens F, Pirenne J, Monbaliu D, Roskams T, Verbeken EK, Neyrinck AP, Van Raemdonck DE, Verleden GM, Vos R.

Transplantation. 2018 Oct;102(10):1747-1755. doi: 10.1097/TP.0000000000002198. Review.

PMID:
29596117
35.

Immediate post-operative broncho-alveolar lavage IL-6 and IL-8 are associated with early outcomes after lung transplantation.

Verleden SE, Martens A, Ordies S, Neyrinck AP, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.

Clin Transplant. 2018 Apr;32(4):e13219. doi: 10.1111/ctr.13219. Epub 2018 Feb 23.

PMID:
29405435
36.

Prevention of chronic rejection after lung transplantation.

Van Herck A, Verleden SE, Vanaudenaerde BM, Verleden GM, Vos R.

J Thorac Dis. 2017 Dec;9(12):5472-5488. doi: 10.21037/jtd.2017.11.85. Review.

37.

Recipient selection process and listing for lung transplantation.

Verleden GM, Dupont L, Yserbyt J, Schaevers V, Van Raemdonck D, Neyrinck A, Vos R.

J Thorac Dis. 2017 Sep;9(9):3372-3384. doi: 10.21037/jtd.2017.08.90. Review.

38.

Toronto bridges to successful lung transplantation.

Van Raemdonck D, Neyrinck A, Vos R, Verleden GM.

J Thorac Cardiovasc Surg. 2018 Mar;155(3):1329-1330. doi: 10.1016/j.jtcvs.2017.10.103. Epub 2017 Nov 7. No abstract available.

PMID:
29198806
39.

Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.

Verleden SE, Vanaudenaerde BM, Emonds MP, Van Raemdonck DE, Neyrinck AP, Verleden GM, Vos R.

Eur Respir J. 2017 Nov 16;50(5). pii: 1701248. doi: 10.1183/13993003.01248-2017. Print 2017 Nov.

40.

How Would You Grade Our Progress in Primary Graft Dysfunction after Lung Transplantation?

Neyrink A, Verleden GM.

Am J Respir Crit Care Med. 2018 Jan 15;197(2):155-157. doi: 10.1164/rccm.201709-1952ED. No abstract available.

PMID:
29048930
41.

Feasibility of diaphragm pacing in patients after bilateral lung transplantation.

Testelmans D, Nafteux P, Van Cromphaut S, Vrijsen B, Vos R, De Leyn P, Decaluwé H, Van Raemdonck D, Verleden GM, Buyse B.

Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13134. Epub 2017 Oct 26.

PMID:
28990225
42.

Chronic lung allograft dysfunction phenotypes and treatment.

Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM.

J Thorac Dis. 2017 Aug;9(8):2650-2659. doi: 10.21037/jtd.2017.07.81. Review.

43.

Solid Organ Transplantation in Sarcoidosis.

Yserbyt J, Wuyts WA, Verleden SE, Verleden GM, Van Raemdonck DE, Verbeken EK, Vanaudenaerde BM, Vos R.

Semin Respir Crit Care Med. 2017 Aug;38(4):538-545. doi: 10.1055/s-0037-1602383. Epub 2017 Jul 27. Review. No abstract available.

PMID:
28750467
44.

Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Van Raemdonck DE, Verleden GM, Roobrouck VD, Claes S, Schols D, Verbeken E, Verfaillie CM, Neyrinck AP.

Stem Cell Res Ther. 2017 Jul 5;8(1):159. doi: 10.1186/s13287-017-0603-5.

45.

Statins in lung transplantation: A treatment option for every patient?

Verleden GM, Vos R.

J Heart Lung Transplant. 2017 Sep;36(9):936-937. doi: 10.1016/j.healun.2017.05.027. Epub 2017 May 25. No abstract available.

PMID:
28599875
46.

A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors.

Martens A, Van Raemdonck DE, Smits J, Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM, Degezelle K, Desschans B, Neyrinck AP.

Transpl Int. 2017 Oct;30(10):1002-1010. doi: 10.1111/tri.12990. Epub 2017 Jul 13.

47.

A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury.

Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Verleden GM, Verbeken EK, Van Raemdonck DE, Claes S, Schols D, Chalopin M, Katz I, Farjot G, Neyrinck AP.

Med Gas Res. 2017 Mar 30;7(1):28-36. doi: 10.4103/2045-9912.202907. eCollection 2017 Jan-Mar.

48.

The Effect of Immunosuppression on Airway Integrity.

Bellon H, Vandermeulen E, Verleden SE, Heigl T, Vriens H, Lammertyn E, Verlinden L, Vanhove T, Verstuyf M, Hoet P, Vos R, Verleden GM, Vanaudenaerde BM.

Transplantation. 2017 Dec;101(12):2855-2861. doi: 10.1097/TP.0000000000001809.

PMID:
28471870
49.

Endoscopic advanced imaging of the respiratory tract: exploring probe-based confocal laser endomicroscopy in emphysema.

Yserbyt J, Dooms C, Janssens W, Verleden GM.

Thorax. 2018 Feb;73(2):188-190. doi: 10.1136/thoraxjnl-2016-209746. Epub 2017 Apr 14.

PMID:
28411249
50.

Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.

Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12983. Epub 2017 May 8.

PMID:
28383790

Supplemental Content

Loading ...
Support Center